Could a diabetes drug protect kidneys in type 1 patients? new trial aims to find out.
Disease control
Recruiting now
This study tests whether the drug sotagliflozin can slow kidney function loss in 150 people with type 1 diabetes and moderate to severe kidney disease. Participants will take either the drug or a placebo daily for 3 years, while following a plan to prevent a serious side effect c…
Phase: PHASE3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated May 11, 2026 20:48 UTC